nodes	percent_of_prediction	percent_of_DWPC	metapath
Icosapent ethyl—Dihomo-gamma-linolenic acid—PTGS2—bone cancer	0.0208	0.56	CrCbGaD
Icosapent ethyl—Icosapent—PTGS2—bone cancer	0.0163	0.44	CrCbGaD
Icosapent ethyl—Proctalgia—Epirubicin—bone cancer	0.0121	0.0125	CcSEcCtD
Icosapent ethyl—Sudden death—Methotrexate—bone cancer	0.0118	0.0123	CcSEcCtD
Icosapent ethyl—Peripheral vascular disorder—Epirubicin—bone cancer	0.0115	0.012	CcSEcCtD
Icosapent ethyl—Pain—Carboplatin—bone cancer	0.0115	0.0119	CcSEcCtD
Icosapent ethyl—Proctalgia—Doxorubicin—bone cancer	0.0112	0.0116	CcSEcCtD
Icosapent ethyl—Peripheral vascular disorder—Doxorubicin—bone cancer	0.0107	0.0111	CcSEcCtD
Icosapent ethyl—Body temperature increased—Carboplatin—bone cancer	0.0106	0.011	CcSEcCtD
Icosapent ethyl—Fluid retention—Cisplatin—bone cancer	0.0105	0.0109	CcSEcCtD
Icosapent ethyl—Anorectal discomfort—Epirubicin—bone cancer	0.0103	0.0107	CcSEcCtD
Icosapent ethyl—Polyp—Methotrexate—bone cancer	0.00993	0.0103	CcSEcCtD
Icosapent ethyl—Anorectal discomfort—Doxorubicin—bone cancer	0.00957	0.00994	CcSEcCtD
Icosapent ethyl—Generalised oedema—Epirubicin—bone cancer	0.00951	0.00987	CcSEcCtD
Icosapent ethyl—Enlargement abdomen—Epirubicin—bone cancer	0.0094	0.00976	CcSEcCtD
Icosapent ethyl—Polyp—Epirubicin—bone cancer	0.00929	0.00965	CcSEcCtD
Icosapent ethyl—Cyst—Methotrexate—bone cancer	0.00904	0.00939	CcSEcCtD
Icosapent ethyl—Generalised oedema—Doxorubicin—bone cancer	0.0088	0.00913	CcSEcCtD
Icosapent ethyl—Enlargement abdomen—Doxorubicin—bone cancer	0.0087	0.00903	CcSEcCtD
Icosapent ethyl—Polyp—Doxorubicin—bone cancer	0.0086	0.00893	CcSEcCtD
Icosapent ethyl—Cyst—Epirubicin—bone cancer	0.00846	0.00878	CcSEcCtD
Icosapent ethyl—Laryngitis—Epirubicin—bone cancer	0.00784	0.00815	CcSEcCtD
Icosapent ethyl—Hyperlipidaemia—Epirubicin—bone cancer	0.00784	0.00815	CcSEcCtD
Icosapent ethyl—Cyst—Doxorubicin—bone cancer	0.00783	0.00813	CcSEcCtD
Icosapent ethyl—Fungal infection—Methotrexate—bone cancer	0.00782	0.00813	CcSEcCtD
Icosapent ethyl—Fungal infection—Epirubicin—bone cancer	0.00732	0.0076	CcSEcCtD
Icosapent ethyl—Hyperlipidaemia—Doxorubicin—bone cancer	0.00726	0.00754	CcSEcCtD
Icosapent ethyl—Laryngitis—Doxorubicin—bone cancer	0.00726	0.00754	CcSEcCtD
Icosapent ethyl—Aspartate aminotransferase increased—Cisplatin—bone cancer	0.0072	0.00747	CcSEcCtD
Icosapent ethyl—Fungal infection—Doxorubicin—bone cancer	0.00678	0.00704	CcSEcCtD
Icosapent ethyl—Pancreatitis—Cisplatin—bone cancer	0.00677	0.00703	CcSEcCtD
Icosapent ethyl—Viral infection—Epirubicin—bone cancer	0.00626	0.0065	CcSEcCtD
Icosapent ethyl—Cough increased—Epirubicin—bone cancer	0.00618	0.00641	CcSEcCtD
Icosapent ethyl—Acute coronary syndrome—Cisplatin—bone cancer	0.00607	0.00631	CcSEcCtD
Icosapent ethyl—Myocardial infarction—Cisplatin—bone cancer	0.00604	0.00627	CcSEcCtD
Icosapent ethyl—Melaena—Methotrexate—bone cancer	0.0059	0.00613	CcSEcCtD
Icosapent ethyl—Viral infection—Doxorubicin—bone cancer	0.00579	0.00602	CcSEcCtD
Icosapent ethyl—Neck pain—Epirubicin—bone cancer	0.00572	0.00594	CcSEcCtD
Icosapent ethyl—Cough increased—Doxorubicin—bone cancer	0.00571	0.00594	CcSEcCtD
Icosapent ethyl—Eructation—Epirubicin—bone cancer	0.00556	0.00577	CcSEcCtD
Icosapent ethyl—Melaena—Epirubicin—bone cancer	0.00552	0.00574	CcSEcCtD
Icosapent ethyl—Neoplasm—Methotrexate—bone cancer	0.00546	0.00567	CcSEcCtD
Icosapent ethyl—Colitis—Epirubicin—bone cancer	0.00543	0.00564	CcSEcCtD
Icosapent ethyl—Fluid retention—Epirubicin—bone cancer	0.00537	0.00557	CcSEcCtD
Icosapent ethyl—Neck pain—Doxorubicin—bone cancer	0.0053	0.0055	CcSEcCtD
Icosapent ethyl—Lymphadenopathy—Methotrexate—bone cancer	0.00514	0.00534	CcSEcCtD
Icosapent ethyl—Eructation—Doxorubicin—bone cancer	0.00514	0.00534	CcSEcCtD
Icosapent ethyl—Neoplasm—Epirubicin—bone cancer	0.00511	0.00531	CcSEcCtD
Icosapent ethyl—Melaena—Doxorubicin—bone cancer	0.00511	0.00531	CcSEcCtD
Icosapent ethyl—Colitis—Doxorubicin—bone cancer	0.00502	0.00522	CcSEcCtD
Icosapent ethyl—Fluid retention—Doxorubicin—bone cancer	0.00497	0.00516	CcSEcCtD
Icosapent ethyl—Arrhythmia—Cisplatin—bone cancer	0.00494	0.00513	CcSEcCtD
Icosapent ethyl—Alopecia—Cisplatin—bone cancer	0.00489	0.00507	CcSEcCtD
Icosapent ethyl—Malnutrition—Cisplatin—bone cancer	0.00481	0.005	CcSEcCtD
Icosapent ethyl—Lymphadenopathy—Epirubicin—bone cancer	0.00481	0.005	CcSEcCtD
Icosapent ethyl—Neoplasm—Doxorubicin—bone cancer	0.00473	0.00491	CcSEcCtD
Icosapent ethyl—Eczema—Epirubicin—bone cancer	0.00457	0.00474	CcSEcCtD
Icosapent ethyl—Ill-defined disorder—Cisplatin—bone cancer	0.00447	0.00464	CcSEcCtD
Icosapent ethyl—Lymphadenopathy—Doxorubicin—bone cancer	0.00445	0.00462	CcSEcCtD
Icosapent ethyl—Increased appetite—Epirubicin—bone cancer	0.00437	0.00454	CcSEcCtD
Icosapent ethyl—Malaise—Cisplatin—bone cancer	0.00434	0.00451	CcSEcCtD
Icosapent ethyl—Eczema—Doxorubicin—bone cancer	0.00423	0.00439	CcSEcCtD
Icosapent ethyl—Mood swings—Methotrexate—bone cancer	0.00415	0.00431	CcSEcCtD
Icosapent ethyl—Myalgia—Cisplatin—bone cancer	0.0041	0.00426	CcSEcCtD
Icosapent ethyl—Discomfort—Cisplatin—bone cancer	0.00405	0.0042	CcSEcCtD
Icosapent ethyl—Increased appetite—Doxorubicin—bone cancer	0.00404	0.0042	CcSEcCtD
Icosapent ethyl—Migraine—Epirubicin—bone cancer	0.00404	0.0042	CcSEcCtD
Icosapent ethyl—Affect lability—Epirubicin—bone cancer	0.00404	0.0042	CcSEcCtD
Icosapent ethyl—Oedema—Cisplatin—bone cancer	0.00393	0.00408	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Cisplatin—bone cancer	0.00393	0.00408	CcSEcCtD
Icosapent ethyl—Cardiac arrest—Epirubicin—bone cancer	0.0039	0.00405	CcSEcCtD
Icosapent ethyl—Infection—Cisplatin—bone cancer	0.0039	0.00405	CcSEcCtD
Icosapent ethyl—Mood swings—Epirubicin—bone cancer	0.00389	0.00404	CcSEcCtD
Icosapent ethyl—Tachycardia—Cisplatin—bone cancer	0.00383	0.00398	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Cisplatin—bone cancer	0.0038	0.00394	CcSEcCtD
Icosapent ethyl—Asthma—Methotrexate—bone cancer	0.00379	0.00394	CcSEcCtD
Icosapent ethyl—Anorexia—Cisplatin—bone cancer	0.00374	0.00389	CcSEcCtD
Icosapent ethyl—Migraine—Doxorubicin—bone cancer	0.00374	0.00388	CcSEcCtD
Icosapent ethyl—Affect lability—Doxorubicin—bone cancer	0.00374	0.00388	CcSEcCtD
Icosapent ethyl—Pancreatitis—Methotrexate—bone cancer	0.00372	0.00386	CcSEcCtD
Icosapent ethyl—Aspartate aminotransferase increased—Epirubicin—bone cancer	0.0037	0.00384	CcSEcCtD
Icosapent ethyl—Gastritis—Epirubicin—bone cancer	0.00363	0.00377	CcSEcCtD
Icosapent ethyl—Alanine aminotransferase increased—Epirubicin—bone cancer	0.00362	0.00376	CcSEcCtD
Icosapent ethyl—Cardiac arrest—Doxorubicin—bone cancer	0.00361	0.00375	CcSEcCtD
Icosapent ethyl—Mood swings—Doxorubicin—bone cancer	0.0036	0.00374	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Cisplatin—bone cancer	0.00358	0.00372	CcSEcCtD
Icosapent ethyl—Abdominal distension—Epirubicin—bone cancer	0.00357	0.00371	CcSEcCtD
Icosapent ethyl—Asthma—Epirubicin—bone cancer	0.00355	0.00368	CcSEcCtD
Icosapent ethyl—Influenza—Epirubicin—bone cancer	0.00355	0.00368	CcSEcCtD
Icosapent ethyl—Dysphagia—Epirubicin—bone cancer	0.00355	0.00368	CcSEcCtD
Icosapent ethyl—Dyspnoea—Cisplatin—bone cancer	0.0035	0.00364	CcSEcCtD
Icosapent ethyl—Erectile dysfunction—Methotrexate—bone cancer	0.00349	0.00363	CcSEcCtD
Icosapent ethyl—Pancreatitis—Epirubicin—bone cancer	0.00348	0.00361	CcSEcCtD
Icosapent ethyl—Angina pectoris—Epirubicin—bone cancer	0.00346	0.00359	CcSEcCtD
Icosapent ethyl—Aspartate aminotransferase increased—Doxorubicin—bone cancer	0.00342	0.00355	CcSEcCtD
Icosapent ethyl—Decreased appetite—Cisplatin—bone cancer	0.00341	0.00355	CcSEcCtD
Icosapent ethyl—Bronchitis—Epirubicin—bone cancer	0.00341	0.00354	CcSEcCtD
Icosapent ethyl—Pneumonia—Methotrexate—bone cancer	0.0034	0.00353	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Cisplatin—bone cancer	0.00339	0.00352	CcSEcCtD
Icosapent ethyl—Infestation NOS—Methotrexate—bone cancer	0.00338	0.00351	CcSEcCtD
Icosapent ethyl—Infestation—Methotrexate—bone cancer	0.00338	0.00351	CcSEcCtD
Icosapent ethyl—Gastritis—Doxorubicin—bone cancer	0.00336	0.00349	CcSEcCtD
Icosapent ethyl—Pain—Cisplatin—bone cancer	0.00336	0.00349	CcSEcCtD
Icosapent ethyl—Alanine aminotransferase increased—Doxorubicin—bone cancer	0.00335	0.00348	CcSEcCtD
Icosapent ethyl—Abdominal distension—Doxorubicin—bone cancer	0.0033	0.00343	CcSEcCtD
Icosapent ethyl—Influenza—Doxorubicin—bone cancer	0.00328	0.00341	CcSEcCtD
Icosapent ethyl—Dysphagia—Doxorubicin—bone cancer	0.00328	0.00341	CcSEcCtD
Icosapent ethyl—Asthma—Doxorubicin—bone cancer	0.00328	0.00341	CcSEcCtD
Icosapent ethyl—Sweating—Methotrexate—bone cancer	0.00324	0.00337	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Cisplatin—bone cancer	0.00324	0.00336	CcSEcCtD
Icosapent ethyl—Pancreatitis—Doxorubicin—bone cancer	0.00322	0.00334	CcSEcCtD
Icosapent ethyl—Hyperglycaemia—Epirubicin—bone cancer	0.0032	0.00332	CcSEcCtD
Icosapent ethyl—Angina pectoris—Doxorubicin—bone cancer	0.0032	0.00332	CcSEcCtD
Icosapent ethyl—Epistaxis—Methotrexate—bone cancer	0.00319	0.00331	CcSEcCtD
Icosapent ethyl—Pneumonia—Epirubicin—bone cancer	0.00318	0.0033	CcSEcCtD
Icosapent ethyl—Infestation NOS—Epirubicin—bone cancer	0.00316	0.00328	CcSEcCtD
Icosapent ethyl—Infestation—Epirubicin—bone cancer	0.00316	0.00328	CcSEcCtD
Icosapent ethyl—Bronchitis—Doxorubicin—bone cancer	0.00316	0.00328	CcSEcCtD
Icosapent ethyl—Body temperature increased—Cisplatin—bone cancer	0.00311	0.00323	CcSEcCtD
Icosapent ethyl—Sweating—Epirubicin—bone cancer	0.00303	0.00315	CcSEcCtD
Icosapent ethyl—Pharyngitis—Methotrexate—bone cancer	0.00301	0.00313	CcSEcCtD
Icosapent ethyl—Epistaxis—Epirubicin—bone cancer	0.00298	0.0031	CcSEcCtD
Icosapent ethyl—Sinusitis—Epirubicin—bone cancer	0.00297	0.00308	CcSEcCtD
Icosapent ethyl—Hyperglycaemia—Doxorubicin—bone cancer	0.00296	0.00307	CcSEcCtD
Icosapent ethyl—Pneumonia—Doxorubicin—bone cancer	0.00294	0.00306	CcSEcCtD
Icosapent ethyl—Infestation—Doxorubicin—bone cancer	0.00293	0.00304	CcSEcCtD
Icosapent ethyl—Infestation NOS—Doxorubicin—bone cancer	0.00293	0.00304	CcSEcCtD
Icosapent ethyl—Rhinitis—Epirubicin—bone cancer	0.00285	0.00296	CcSEcCtD
Icosapent ethyl—Asthenia—Cisplatin—bone cancer	0.00282	0.00293	CcSEcCtD
Icosapent ethyl—Pharyngitis—Epirubicin—bone cancer	0.00282	0.00293	CcSEcCtD
Icosapent ethyl—Sweating—Doxorubicin—bone cancer	0.00281	0.00291	CcSEcCtD
Icosapent ethyl—Epistaxis—Doxorubicin—bone cancer	0.00276	0.00287	CcSEcCtD
Icosapent ethyl—Sinusitis—Doxorubicin—bone cancer	0.00275	0.00285	CcSEcCtD
Icosapent ethyl—Chills—Methotrexate—bone cancer	0.00272	0.00283	CcSEcCtD
Icosapent ethyl—Alopecia—Methotrexate—bone cancer	0.00268	0.00278	CcSEcCtD
Icosapent ethyl—Malnutrition—Methotrexate—bone cancer	0.00264	0.00274	CcSEcCtD
Icosapent ethyl—Rhinitis—Doxorubicin—bone cancer	0.00263	0.00274	CcSEcCtD
Icosapent ethyl—Pharyngitis—Doxorubicin—bone cancer	0.00261	0.00271	CcSEcCtD
Icosapent ethyl—Dysgeusia—Methotrexate—bone cancer	0.00259	0.00269	CcSEcCtD
Icosapent ethyl—Back pain—Methotrexate—bone cancer	0.00255	0.00265	CcSEcCtD
Icosapent ethyl—Chills—Epirubicin—bone cancer	0.00255	0.00265	CcSEcCtD
Icosapent ethyl—Arrhythmia—Epirubicin—bone cancer	0.00254	0.00263	CcSEcCtD
Icosapent ethyl—Alopecia—Epirubicin—bone cancer	0.00251	0.00261	CcSEcCtD
Icosapent ethyl—Vomiting—Cisplatin—bone cancer	0.0025	0.00259	CcSEcCtD
Icosapent ethyl—Rash—Cisplatin—bone cancer	0.00248	0.00257	CcSEcCtD
Icosapent ethyl—Dermatitis—Cisplatin—bone cancer	0.00247	0.00257	CcSEcCtD
Icosapent ethyl—Malnutrition—Epirubicin—bone cancer	0.00247	0.00257	CcSEcCtD
Icosapent ethyl—Ill-defined disorder—Methotrexate—bone cancer	0.00245	0.00255	CcSEcCtD
Icosapent ethyl—Dysgeusia—Epirubicin—bone cancer	0.00242	0.00251	CcSEcCtD
Icosapent ethyl—Back pain—Epirubicin—bone cancer	0.00239	0.00248	CcSEcCtD
Icosapent ethyl—Malaise—Methotrexate—bone cancer	0.00238	0.00247	CcSEcCtD
Icosapent ethyl—Vertigo—Methotrexate—bone cancer	0.00237	0.00246	CcSEcCtD
Icosapent ethyl—Chills—Doxorubicin—bone cancer	0.00236	0.00245	CcSEcCtD
Icosapent ethyl—Arrhythmia—Doxorubicin—bone cancer	0.00235	0.00244	CcSEcCtD
Icosapent ethyl—Alopecia—Doxorubicin—bone cancer	0.00232	0.00241	CcSEcCtD
Icosapent ethyl—Cough—Methotrexate—bone cancer	0.0023	0.00239	CcSEcCtD
Icosapent ethyl—Ill-defined disorder—Epirubicin—bone cancer	0.00229	0.00238	CcSEcCtD
Icosapent ethyl—Malnutrition—Doxorubicin—bone cancer	0.00229	0.00238	CcSEcCtD
Icosapent ethyl—Chest pain—Methotrexate—bone cancer	0.00225	0.00234	CcSEcCtD
Icosapent ethyl—Myalgia—Methotrexate—bone cancer	0.00225	0.00234	CcSEcCtD
Icosapent ethyl—Arthralgia—Methotrexate—bone cancer	0.00225	0.00234	CcSEcCtD
Icosapent ethyl—Dysgeusia—Doxorubicin—bone cancer	0.00224	0.00233	CcSEcCtD
Icosapent ethyl—Malaise—Epirubicin—bone cancer	0.00223	0.00231	CcSEcCtD
Icosapent ethyl—Discomfort—Methotrexate—bone cancer	0.00222	0.00231	CcSEcCtD
Icosapent ethyl—Vertigo—Epirubicin—bone cancer	0.00222	0.00231	CcSEcCtD
Icosapent ethyl—Syncope—Epirubicin—bone cancer	0.00222	0.0023	CcSEcCtD
Icosapent ethyl—Back pain—Doxorubicin—bone cancer	0.00221	0.0023	CcSEcCtD
Icosapent ethyl—Loss of consciousness—Epirubicin—bone cancer	0.00217	0.00226	CcSEcCtD
Icosapent ethyl—Cough—Epirubicin—bone cancer	0.00216	0.00224	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Methotrexate—bone cancer	0.00216	0.00224	CcSEcCtD
Icosapent ethyl—Infection—Methotrexate—bone cancer	0.00214	0.00222	CcSEcCtD
Icosapent ethyl—Hypertension—Epirubicin—bone cancer	0.00213	0.00222	CcSEcCtD
Icosapent ethyl—Ill-defined disorder—Doxorubicin—bone cancer	0.00212	0.0022	CcSEcCtD
Icosapent ethyl—Arthralgia—Epirubicin—bone cancer	0.0021	0.00219	CcSEcCtD
Icosapent ethyl—Chest pain—Epirubicin—bone cancer	0.0021	0.00219	CcSEcCtD
Icosapent ethyl—Myalgia—Epirubicin—bone cancer	0.0021	0.00219	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Methotrexate—bone cancer	0.00208	0.00216	CcSEcCtD
Icosapent ethyl—Discomfort—Epirubicin—bone cancer	0.00208	0.00216	CcSEcCtD
Icosapent ethyl—Malaise—Doxorubicin—bone cancer	0.00206	0.00214	CcSEcCtD
Icosapent ethyl—Dry mouth—Epirubicin—bone cancer	0.00206	0.00214	CcSEcCtD
Icosapent ethyl—Vertigo—Doxorubicin—bone cancer	0.00205	0.00213	CcSEcCtD
Icosapent ethyl—Anorexia—Methotrexate—bone cancer	0.00205	0.00213	CcSEcCtD
Icosapent ethyl—Syncope—Doxorubicin—bone cancer	0.00205	0.00213	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Epirubicin—bone cancer	0.00202	0.0021	CcSEcCtD
Icosapent ethyl—Oedema—Epirubicin—bone cancer	0.00202	0.0021	CcSEcCtD
Icosapent ethyl—Loss of consciousness—Doxorubicin—bone cancer	0.00201	0.00209	CcSEcCtD
Icosapent ethyl—Infection—Epirubicin—bone cancer	0.002	0.00208	CcSEcCtD
Icosapent ethyl—Cough—Doxorubicin—bone cancer	0.002	0.00207	CcSEcCtD
Icosapent ethyl—Shock—Epirubicin—bone cancer	0.00198	0.00206	CcSEcCtD
Icosapent ethyl—Hypertension—Doxorubicin—bone cancer	0.00197	0.00205	CcSEcCtD
Icosapent ethyl—Tachycardia—Epirubicin—bone cancer	0.00197	0.00204	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Methotrexate—bone cancer	0.00196	0.00204	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Epirubicin—bone cancer	0.00195	0.00203	CcSEcCtD
Icosapent ethyl—Insomnia—Methotrexate—bone cancer	0.00195	0.00202	CcSEcCtD
Icosapent ethyl—Arthralgia—Doxorubicin—bone cancer	0.00195	0.00202	CcSEcCtD
Icosapent ethyl—Chest pain—Doxorubicin—bone cancer	0.00195	0.00202	CcSEcCtD
Icosapent ethyl—Myalgia—Doxorubicin—bone cancer	0.00195	0.00202	CcSEcCtD
Icosapent ethyl—Discomfort—Doxorubicin—bone cancer	0.00192	0.002	CcSEcCtD
Icosapent ethyl—Anorexia—Epirubicin—bone cancer	0.00192	0.002	CcSEcCtD
Icosapent ethyl—Dyspnoea—Methotrexate—bone cancer	0.00192	0.002	CcSEcCtD
Icosapent ethyl—Dry mouth—Doxorubicin—bone cancer	0.0019	0.00198	CcSEcCtD
Icosapent ethyl—Dyspepsia—Methotrexate—bone cancer	0.0019	0.00197	CcSEcCtD
Icosapent ethyl—Decreased appetite—Methotrexate—bone cancer	0.00187	0.00195	CcSEcCtD
Icosapent ethyl—Oedema—Doxorubicin—bone cancer	0.00187	0.00194	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Doxorubicin—bone cancer	0.00187	0.00194	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Methotrexate—bone cancer	0.00186	0.00193	CcSEcCtD
Icosapent ethyl—Infection—Doxorubicin—bone cancer	0.00185	0.00193	CcSEcCtD
Icosapent ethyl—Pain—Methotrexate—bone cancer	0.00184	0.00191	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Epirubicin—bone cancer	0.00184	0.00191	CcSEcCtD
Icosapent ethyl—Shock—Doxorubicin—bone cancer	0.00184	0.00191	CcSEcCtD
Icosapent ethyl—Insomnia—Epirubicin—bone cancer	0.00182	0.00189	CcSEcCtD
Icosapent ethyl—Tachycardia—Doxorubicin—bone cancer	0.00182	0.00189	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Doxorubicin—bone cancer	0.0018	0.00187	CcSEcCtD
Icosapent ethyl—Dyspnoea—Epirubicin—bone cancer	0.0018	0.00187	CcSEcCtD
Icosapent ethyl—Anorexia—Doxorubicin—bone cancer	0.00178	0.00185	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Methotrexate—bone cancer	0.00178	0.00184	CcSEcCtD
Icosapent ethyl—Dyspepsia—Epirubicin—bone cancer	0.00178	0.00184	CcSEcCtD
Icosapent ethyl—Decreased appetite—Epirubicin—bone cancer	0.00175	0.00182	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Epirubicin—bone cancer	0.00174	0.00181	CcSEcCtD
Icosapent ethyl—Constipation—Epirubicin—bone cancer	0.00173	0.00179	CcSEcCtD
Icosapent ethyl—Pain—Epirubicin—bone cancer	0.00173	0.00179	CcSEcCtD
Icosapent ethyl—Body temperature increased—Methotrexate—bone cancer	0.0017	0.00177	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.0017	0.00177	CcSEcCtD
Icosapent ethyl—Insomnia—Doxorubicin—bone cancer	0.00169	0.00175	CcSEcCtD
Icosapent ethyl—Dyspnoea—Doxorubicin—bone cancer	0.00166	0.00173	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Epirubicin—bone cancer	0.00166	0.00173	CcSEcCtD
Icosapent ethyl—Dyspepsia—Doxorubicin—bone cancer	0.00164	0.00171	CcSEcCtD
Icosapent ethyl—Decreased appetite—Doxorubicin—bone cancer	0.00162	0.00169	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Doxorubicin—bone cancer	0.00161	0.00167	CcSEcCtD
Icosapent ethyl—Constipation—Doxorubicin—bone cancer	0.0016	0.00166	CcSEcCtD
Icosapent ethyl—Pain—Doxorubicin—bone cancer	0.0016	0.00166	CcSEcCtD
Icosapent ethyl—Body temperature increased—Epirubicin—bone cancer	0.00159	0.00166	CcSEcCtD
Icosapent ethyl—Asthenia—Methotrexate—bone cancer	0.00155	0.00161	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Doxorubicin—bone cancer	0.00154	0.0016	CcSEcCtD
Icosapent ethyl—Pruritus—Methotrexate—bone cancer	0.00153	0.00158	CcSEcCtD
Icosapent ethyl—Body temperature increased—Doxorubicin—bone cancer	0.00148	0.00153	CcSEcCtD
Icosapent ethyl—Asthenia—Epirubicin—bone cancer	0.00145	0.0015	CcSEcCtD
Icosapent ethyl—Pruritus—Epirubicin—bone cancer	0.00143	0.00148	CcSEcCtD
Icosapent ethyl—Dizziness—Methotrexate—bone cancer	0.00143	0.00148	CcSEcCtD
Icosapent ethyl—Vomiting—Methotrexate—bone cancer	0.00137	0.00142	CcSEcCtD
Icosapent ethyl—Rash—Methotrexate—bone cancer	0.00136	0.00141	CcSEcCtD
Icosapent ethyl—Dermatitis—Methotrexate—bone cancer	0.00136	0.00141	CcSEcCtD
Icosapent ethyl—Asthenia—Doxorubicin—bone cancer	0.00134	0.00139	CcSEcCtD
Icosapent ethyl—Dizziness—Epirubicin—bone cancer	0.00133	0.00139	CcSEcCtD
Icosapent ethyl—Pruritus—Doxorubicin—bone cancer	0.00132	0.00137	CcSEcCtD
Icosapent ethyl—Vomiting—Epirubicin—bone cancer	0.00128	0.00133	CcSEcCtD
Icosapent ethyl—Rash—Epirubicin—bone cancer	0.00127	0.00132	CcSEcCtD
Icosapent ethyl—Dermatitis—Epirubicin—bone cancer	0.00127	0.00132	CcSEcCtD
Icosapent ethyl—Dizziness—Doxorubicin—bone cancer	0.00123	0.00128	CcSEcCtD
Icosapent ethyl—Vomiting—Doxorubicin—bone cancer	0.00119	0.00123	CcSEcCtD
Icosapent ethyl—Rash—Doxorubicin—bone cancer	0.00118	0.00122	CcSEcCtD
Icosapent ethyl—Dermatitis—Doxorubicin—bone cancer	0.00118	0.00122	CcSEcCtD
